Relmada Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Coral Gables, FL
RLMD chart
What traders are saying about $RLMD
Latest postsRelmada Therapeutics, Inc. news
- Relmada Therapeutics, Inc. Estimates – NASDAQ:RLMD
TradingView ·
- 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Yahoo Finance ·
- Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Yahoo Finance ·
- After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)
Yahoo Finance ·
- Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now
Yahoo Finance ·
- Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround
Yahoo Finance ·
- Relmada Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- Relmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ...
Yahoo Finance ·
- Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
Yahoo Finance ·
- Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Yahoo Finance ·
- Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
Yahoo Finance ·
Relmada Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $0 | $0 | $0 | -$157.0M |
| Diluted EPS | $-1.45 | $-2.65 | $-3.28 | $-5.30 |
| Total assets (year end) | $94.0M | $45.8M | $97.6M | $152.9M |
| Cash and equivalents (year end) | $3.5M | $3.9M | $4.1M | $5.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- DEF 14APROXY STATEMENT
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
About Relmada Therapeutics, Inc.
- Ticker
- RLMD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Coral Gables, FL
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1553643
- Former names
- CAMP NINE, INC.
Frequently asked questions
What exchange is Relmada Therapeutics, Inc. listed on?
Relmada Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RLMD.
What industry is Relmada Therapeutics, Inc. in?
Relmada Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Relmada Therapeutics, Inc. headquartered?
Relmada Therapeutics, Inc.'s business address on file with the SEC is in Coral Gables, FL.
When does Relmada Therapeutics, Inc.'s fiscal year end?
Relmada Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Relmada Therapeutics, Inc. report?
Relmada Therapeutics, Inc. reported $5,129 in revenue for calendar year 2013, according to its SEC filings.